Philip Komarnitsky

Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription

Philip Komarnitsky, Eun‐Jung Cho, Stephen Buratowski · Genes & Development · 2000 · 1.1K citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

Fiona Blackhall, Kevin Jao, Laurent Greillier et al. · Journal of Thoracic Oncology · 2021 · 258 citations · Full text

Medicine, Oncology, Pharmacology +16

Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study

Melissa L. Johnson, Zanete Zvirbule, Åslaug Helland et al. · Journal of Thoracic Oncology · 2021 · 156 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Histone-like TAFs Are Essential for Transcription In Vivo

Bertha Michel, Philip Komarnitsky, Stephen Buratowski · Molecular Cell · 1998 · 98 citations · Full text

Life Sciences, Genetics, Molecular Biology +7

ADR1 Activation Domains Contact the Histone Acetyltransferase GCN5 and the Core Transcriptional Factor TFIIB

Y. C. Chiang, Philip Komarnitsky, Dan Chase et al. · Journal of Biological Chemistry · 1996 · 85 citations · Full text

Life Sciences, Genetics, Molecular Biology +17